CPHL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Citi Pharma Ltd

Watchlist Manager

Watchlist

Price: 71.86 PKR -0.42% Market Closed

Market Cap: Rs16.4B

C	Citi Pharma Ltd KAR:CPHL	PK

Profitability Summary

Citi Pharma Ltd's profitability score is 50/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

18%

Sustainable 3Y Average Gross Margin

14%

Gross Margin is Increasing

12% > 18%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

11%

Operating Margin is Increasing

9% > 15%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

5% > 8%

Negative Free Cash Flow Margin

-6%

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-12% > -6%

Positive ROE

13%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

13% > 12%

View All

Hide

Collapse

50 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.